is tirzepatide compounded Weight Loss Program | GLP-1 Treatment Compounded Tirzepatide 2 Month Program

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes but now FDA approved for chronic weight management in overweight and obese individuals

By suppressing appetite and controlling cravings, Semaglutide provides more immediate results

Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, et al

The 200 to 500mcg figures widely used across clinic and community contexts are derived from animal extrapolation and accumulated self-experimentation, not controlled human trials

When you stop the medication, ghrelin levels surge back within days, and many patients report intense cravings and constant hunger within 1-2 weeks